HOFSETH BIOCARE ASA: årsregnskap 2016 vs 2015
Shrank 64% on revenue, weaker earnings, cash halved-plus
approved 2017-03-31; registry 2017-07-29; journal 2017 773168
Summary
What changed
Comparing Årsregnskap 2016 with 2015 for HOFSETH BIOCARE ASA. Revenue 54.78m NOK → 19.75m NOK (-63.9%). Net result -100.20m NOK → -146.18m NOK. Equity 50.45m NOK → 73.85m NOK.
On the constructive side: equity strengthened. Pressures included: revenue fell; net result weakened; cash fell.
Also worth watching: paid-in equity reduced; book investments changed. All figures are taken from the published annual accounts for HOFSETH BIOCARE ASA.
At a glance
Scorecard
What improved
-
↑
Equity strengthened
Book equity 50.45m NOK → 73.85m NOK (equity ratio 25.5% → 43.8%). Calculated
What deteriorated
-
↓
Revenue fell
Operating income / revenue moved from 54.78m NOK to 19.75m NOK (-63.9% YoY). Calculated
-
↓
Net result weakened
Net result -100.20m NOK → -146.18m NOK (net margin -182.9% → -740.1%). Calculated
-
↓
Cash fell
Bank deposits 28.53m NOK → 14.12m NOK (-50.5% YoY). Calculated
-
↓
Current ratio dropped below 1×
Current ratio 1.35× → 0.62× — short-term liabilities now exceed liquid/current assets on the published lines. Calculated
-
↓
COGS moved
COGS / varekostnad 67.82m NOK → 6.10bn NOK (+8895.0% YoY). Calculated
Things to notice
-
·
Paid-in equity reduced
Paid-in equity fell 110.41m NOK → 233.5k NOK — check capital reduction, conversion, or reclassification. Interpretation
-
·
Book investments changed
Investment / intangible book value 12.10m NOK → 24.62m NOK. Reported fact